<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04777344</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-300006654</org_study_id>
    <nct_id>NCT04777344</nct_id>
  </id_info>
  <brief_title>Clinical Effort Against Smoke Exposure in Cystic Fibrosis</brief_title>
  <acronym>CEASE-CF</acronym>
  <official_title>Clinical Effort Against Smoke Exposure in Cystic Fibrosis (CEASE-CF)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alabama at Birmingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cystic Fibrosis Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Alabama at Birmingham</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will test the feasibility, acceptability, and preliminary efficacy of a&#xD;
      multi-component smoking cessation intervention tailored to the needs of caregivers of&#xD;
      children with CF and delivered in clinical settings as part of routine CF care. The ultimate&#xD;
      goal of this effort is to reduce the exposure of children and adolescents with CF to tobacco&#xD;
      smoke.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single-center, randomized, open-label study to test the feasibility and&#xD;
      acceptability (primary outcomes) and preliminary efficacy (secondary outcome) of a&#xD;
      multi-component smoking-cessation intervention delivered by a tobacco treatment specialist&#xD;
      (TTS) integrated in the multidisciplinary CF care team.&#xD;
&#xD;
      The intervention will be tested in a two-group design with a 2:1 allocation. Participants&#xD;
      (dyads of caregiver/CF child) will be randomized to either intervention or control group. The&#xD;
      intervention group (N=24) will receive the multi-component intervention (intake assessment,&#xD;
      follow-up, help with obtaining nicotine replacement therapy, and CF-specific smoke exposure&#xD;
      education). The control group (N=12) will receive usual care plus CF-specific smoke exposure&#xD;
      education.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 8, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 15, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>single-center, randomized, open-label study</intervention_model_description>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intervention feasibility</measure>
    <time_frame>6 months</time_frame>
    <description>Participant drop-out rates and time added to the clinical encounter</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intervention acceptability</measure>
    <time_frame>6 months</time_frame>
    <description>Proportion of caregivers who accepted participation; Participant and provider satisfaction with the intervention on a 1-5 Likert scale; Perceived effectiveness of the intervention on a 1-5 Likert scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Self-reported caregiver cessation</measure>
    <time_frame>6 months</time_frame>
    <description>7-day point prevalence of abstinence measured at 1, 3, and 6 months; Number of cigarettes smoked in the past 7 days, measured at 1, 3, and 6 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Child smoke exposure</measure>
    <time_frame>6 months</time_frame>
    <description>Biochemically verified with a hair nicotine sample at baseline, 3 months, and 6 months</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Cystic Fibrosis</condition>
  <arm_group>
    <arm_group_label>Intervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The intervention group will receive the multi-component intervention (counseling with intake assessment, follow-up, help obtaining nicotine replacement therapy, and CF-specific smoke exposure education)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The control group will receive usual care plus CF-specific smoke exposure education.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Tobacco Treatment Specialist (TTS) intervention</intervention_name>
    <description>A trained Tobacco Treatment specialist (TTS) embedded in the multi-disciplinary CF care team will provide tobacco use counseling to smoking caregivers of children with CF.</description>
    <arm_group_label>Intervention group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult familial caregiver of a child with CF aged &lt;18 years&#xD;
&#xD;
          -  Speak English&#xD;
&#xD;
          -  Report smoking at least 1 cigarette in the previous week&#xD;
&#xD;
          -  Not enrolled in a smoking cessation program&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Do not report smoking at least 1 cigarette in the previous week&#xD;
&#xD;
          -  Currently enrolled in a smoking cessation program.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Gabriela Oates, PhD</last_name>
    <phone>(205)638-6908</phone>
    <email>goates@uab.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Robin Guers</last_name>
    <phone>(205)422-4452</phone>
    <email>rgeurs@peds.uab.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35233</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gabriela R Oates, PhD</last_name>
      <phone>205-638-5289</phone>
      <email>goates@uab.edu</email>
    </contact>
    <contact_backup>
      <last_name>Heather A Hathorne</last_name>
      <phone>(205) 638-9568</phone>
      <email>hhathorne@peds.uab.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Gabriela R Oates, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>February 23, 2021</study_first_submitted>
  <study_first_submitted_qc>February 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 2, 2021</study_first_posted>
  <last_update_submitted>July 13, 2021</last_update_submitted>
  <last_update_submitted_qc>July 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Alabama at Birmingham</investigator_affiliation>
    <investigator_full_name>Gabriela R Oates</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>caregivers</keyword>
  <keyword>tobacco</keyword>
  <keyword>smoke exposure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cystic Fibrosis</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

